Where the medicinal product falls exclusively within the scope of the Annex to Regulation (EC) No 726/2004 of the European Parliament and of the Council [1], the notified body shall seek the opinion of the EMA.
I gcás ina dtagann an táirge íocshláinte faoi raon feidhme eisiach na hIarscríbhinne a ghabhann le Rialachán (CE) Uimh. 726/2004 [1], iarrfaidh an comhlacht dá dtugtar fógra tuairim EMA.